SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.
SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.
复制标题
DOI：
10.1016/j.virol.2022.09.009
复制
发表时间：
2022-11
期刊：
影响因子：
3.7
通讯作者：
Wan, Xiu-Feng
中科院分区：
文献类型：
--
作者：
Tang, Cynthia Y.;Boftsi, Maria;Staudt, Lindsay;McElroy, Jane A.;Li, Tao;Duong, Sabrina;Ohler, Adrienne;Ritter, Detlef;Hammer, Richard;Hang, Jun;Wan, Xiu-Feng
由于SARS-CoV-2和流感病毒共同传播，这些病毒的共同感染对公共卫生产生了越来越多的关注。为评估2021-2022年流感季节期间SARS-CoV-2和甲型流感病毒合并感染的流行率和临床影响，于2021年10月至2022年1月期间从462名个体中采集了SARS-CoV-2阳性样本。在这些人中，152人流感检测呈阳性，每月合并感染率为7.1%至48%。与Delta变体相比，感染Omicron的个体不太可能合并感染和住院，接受流感疫苗的个体不太可能合并感染。三个人在不同的日期采集了两个样本，三个人在最初的SARS-CoV-2感染后都发生了合并感染。这项研究证明了2021-2022年流感季节期间密苏里州中部地区合并感染的高患病率，三角洲和奥密克隆波之间合并感染患病率的差异，以及流感疫苗接种对合并感染的重要性。
As SARS-CoV-2 and influenza viruses co-circulate, co-infections with these viruses generate an increasing concern to public health. To evaluate the prevalence and clinical impacts of SARS-CoV-2 and influenza A virus co-infections during the 2021–2022 influenza season, SARS-CoV-2-positive samples from 462 individuals were collected from October 2021 to January 2022. Of these individuals, 152 tested positive for influenza, and the monthly co-infection rate ranged from 7.1% to 48%. Compared to the Delta variant, individuals infected with Omicron were less likely to be co-infected and hospitalized, and individuals who received influenza vaccines were less likely to become co-infected. Three individuals had two samples collected on different dates, and all three developed a co-infection after their initial SARS-CoV-2 infection. This study demonstrates high prevalence of co-infections in central Missouri during the 2021–2022 influenza season, differences in co-infection prevalence between the Delta and the Omicron waves, and the importance of influenza vaccinations against co-infections.
登录
查看更多内容
影响因子：
5.4
作者：
Kim EH;Nguyen TQ;Casel MAB;Rollon R;Kim SM;Kim YI;Yu KM;Jang SG;Yang J;Poo H;Jung JU;Choi YK
通讯作者：
Choi YK
影响因子：
13.2
作者：
Zhao H;Lu L;Peng Z;Chen LL;Meng X;Zhang C;Ip JD;Chan WM;Chu AW;Chan KH;Jin DY;Chen H;Yuen KY;To KK
通讯作者：
To KK
DOI：
10.1093/pnasnexus/pgac071
发表时间：
2022-07
期刊：
PNAS nexus
影响因子：
--
作者：
Pawlowski C;Silvert E;O'Horo JC;Lenehan PJ;Challener D;Gnass E;Murugadoss K;Ross J;Speicher L;Geyer H;Venkatakrishnan AJ;Badley AD;Soundararajan V
通讯作者：
Soundararajan V
影响因子：
16.6
作者：
Achdout H;Vitner EB;Politi B;Melamed S;Yahalom-Ronen Y;Tamir H;Erez N;Avraham R;Weiss S;Cherry L;Bar-Haim E;Makdasi E;Gur D;Aftalion M;Chitlaru T;Vagima Y;Paran N;Israely T
通讯作者：
Israely T
DOI：
10.15585/mmwr.mm7029a1
发表时间：
2021-07-23
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Olsen SJ;Winn AK;Budd AP;Prill MM;Steel J;Midgley CM;Kniss K;Burns E;Rowe T;Foust A;Jasso G;Merced-Morales A;Davis CT;Jang Y;Jones J;Daly P;Gubareva L;Barnes J;Kondor R;Sessions W;Smith C;Wentworth DE;Garg S;Havers FP;Fry AM;Hall AJ;Brammer L;Silk BJ
通讯作者：
Silk BJ